Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Covington
Colorcon
Fish and Richardson
Daiichi Sankyo
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office

Generated: June 24, 2018

DrugPatentWatch Database Preview

Beta carotene - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for beta carotene and what is the scope of beta carotene patent protection?

Beta carotene
is the generic ingredient in one branded drug marketed by Roche and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two hundred and eight drug master file entries for beta carotene.
Summary for beta carotene
Medical Subject Heading (MeSH) Categories for beta carotene
Synonyms for beta carotene
.beta. Carotene
.beta.-Carotene
.beta.-Carotene, all-trans-
.beta., .beta.-Carotene
.beta.,.beta.-Carotene
.beta.,.beta.-Carotene, neo B
(1E,3E,5E,7E,9E,11E,13E,15E,17E)-1,18-bis(2,6,6-trimethylcyclohex-1-enyl)-3,7, 12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene
(9Z,13Z)-beta-Carotene
(all-E)-1,1'-(3,7,12,16-Tetramethyl-1,3,5, 7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6, 6-trimethylcyclohexene]
(all-E)-1,1'-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis
(all-E)-1,1'-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene)
(all-E)-1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-Cyclohexene
01YAE03M7J
1,1'-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene
1,1'-(3,7,12,16-Tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethylcyclohexene), (all E)-
1,1'-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl]bis(2,6,6-trimethylcyclohexene)
1,18-Bis(2,6,6-trimethyl-1-cyclohexenyl)-3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonene
1,3,3-trimethyl-2-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]cyclohexene
116-32-5
117179-EP2292227A2
117179-EP2298776A1
2,2'-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaene-1,18-diyl)bis(1,3,3-trimethylcyclohex-1-ene)
3,7,12,16-tetramethyl-1,18-bis-(2,2,6-trimethyl-cyclohexyl)-octadecane
3046-EP2298772A1
3046-EP2308839A1
31797-85-0
7235-40-7
89648336-F9B2-44A0-9BF8-62E73369CB9B
AB00051925_06
AB00051925_07
AB2000280
AC-1869
AC1NQX3D
AC1Q28DI
AKOS015896682
all trans beta-Carotene
all-E-.beta.-Carotene
all-E-b-Carotene
all-epsilon-beta-Carotene
all-trans-.beta.-Carotene
all-trans-b-Carotene
all-trans-beta-Carotene
Ambap17161-33-0
AN-14537
AS-13354
b-Carotene
BC208855
BDBM54988
beta -carotene
beta Carotene (USP)
Beta carotene [USAN:USP]
beta carotene [USAN]
Beta Carotene Natural
Beta Carotene, United States Pharmacopeia (USP) Reference Standard
beta-carotene
beta-Carotene, >=97.0% (UV)
beta-Carotene, all-trans-
beta-Carotene, pharmaceutical secondary standard; traceable to USP
beta-Carotene, Type I, synthetic, >=93% (UV), powder
beta-Carotene, Type II, synthetic, >=95% (HPLC), crystalline
beta-Carotene, Vetec(TM) reagent grade, >=93%
beta-Carotin
beta-Carotine
beta-Karotin
beta,beta-Carotene
beta;-Carotene
Betacarotene
Betacarotene (INN)
Betacarotene [INN]
Betacaroteno
Betacaroteno [INN-Spanish]
Betacaroteno [Spanish]
Betacarotenum
Betacarotenum [INN-Latin]
Betacarotenum [Latin]
BetaVit
BIDD:PXR0110
bmse000832
BSPBio_003404
BT000918
C-23129
C.I. 75130
C.I. Food Orange 5
C02094
C39H54
Carotaben
Carotene Base 80S
Carotene, .beta.
Carotene, Provitamin A
CAS-7235-40-7
CC0205
CCG-36062
CCRIS 3245
CHEBI:17579
CHEMBL1293
CI 40800
CI 75130
cid_5280489
Cyclohexene, 1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis(2,6,6-trimethyl-, (all-E)-
Cyclohexene, 1,1'-(3,7,12,16-tetramethyl-1,3,5,7,9,11,13,15,17-octadecanonaene-1,18-diyl)bis[2,6,6-trimethyl-, (all-E)-
D03101
D0MY8N
DB06755
Diet,beta-carotene supplementation
DR003195
DSSTox_CID_253
DSSTox_GSID_20253
DSSTox_RID_75466
DTXSID3020253
E160A
EC 230-636-6
EINECS 230-636-6
Food orange 5
H982
HMS2091M17
HMS501A12
HSDB 3264
I(2)-Carotene
I06-2213
I14-38736
IDI1_000330
J10299
Karotin
Karotin [Czech]
KPMK
LMPR01070001
LP107876
LS-1621
Lucaratin
Lucarotin
Lurotin
MFCD00001556
MLS001066383
MolPort-001-785-959
N1547
Natural Yellow 26
NCGC00096081-01
NCGC00096081-02
NSC 62794
NSC-755910
NSC62794
NSC755910
OENHQHLEOONYIE-JLTXGRSLSA-N
Pharmakon1600-01500143
Provatene
Provatenol
Provitamin A
Provitamin A1
Q-200706
Rovimix b-carotene
s1767
SBI-0051295.P003
SC-19470
SDCCGMLS-0066579.P001
Serlabo
SMR000112037
Solate
Solatene
Solatene (caps)
Solatene (TN)
Spectrum5_000505
SR-01000763803
SR-01000763803-2
SR-01000763803-4
ST097774
Tox21_111557
trans-.beta.-Carotene
trans-B-Carotene
trans-beta-Carotene
UNII-01YAE03M7J
Vetoron
ZINC6845076
Zlut prirodni 26
Zlut prirodni 26 [Czech]

US Patents and Regulatory Information for beta carotene

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche SOLATENE beta carotene CAPSULE;ORAL 017589-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Dow
Fish and Richardson
Chinese Patent Office
Argus Health
Cerilliant
Julphar
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.